Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
Backgrounds. The aim of this study was to appraise the relationship between serum fragmented cytokeratin-18(CK-18), controlled attenuation parameter (CAP), and liver steatosis assessed by ultrasound (US) in nonalcoholic fatty liver disease (NAFLD) patients. Methods. Patients who underwent abdominal...
Published in: | International Journal of Hepatology |
---|---|
Main Author: | Kosasih S.; Zhi Qin W.; Abdul Rani R.; Abd Hamid N.; Chai Soon N.; Azhar Shah S.; Yaakob Y.; Raja Ali R.A. |
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056513460&doi=10.1155%2f2018%2f9252536&partnerID=40&md5=c4f28d232240ecf9c650ec791092fa70 |
Similar Items
-
Preventive mechanisms of Chinese Tibetan medicine Triphala against nonalcoholic fatty liver disease
by: Jiang Y.; Zhao L.; Ma J.; Yang Y.; Zhang B.; Xu J.; Dhondrup R.; Wong T.W.; Zhang D.
Published: (2024) -
Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?
by: Miptah H.N.; Ramli A.S.; Mohamad M.; Hashim H.; Tharek Z.
Published: (2020) -
Arq ajwain protects nonalcoholic fatty liver disease on high-fat diet-induced obese rat
by: Haque R.; Ahmad A.; Ashraf K.; Akhter H.; Jameel M.; Ali A.; Akhtar W.; Dhaka M.; Rana K.
Published: (2021) -
Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: A randomised placebo-controlled clinical trial
by: Magosso E.; Ansari M.A.; Gopalan Y.; Shuaib I.L.; Wong J.-W.; Khan N.A.K.; Abu Bakar M.R.; Ng B.-H.; Yuen K.-H.
Published: (2013) -
Fructose-drinking water induced nonalcoholic fatty liver disease and ultrastructural alteration of hepatocyte mitochondria in Male wistar rat
by: Mamikutty N.; Thent Z.C.; Haji Suhaimi F.
Published: (2015)